PROCEPT BioRobotics Corp (PRCT)
64.28
+2.53
(+4.10%)
USD |
NASDAQ |
May 03, 16:00
64.28
0.00 (0.00%)
After-Hours: 20:00
PROCEPT BioRobotics Revenue (Quarterly): 44.54M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 44.54M |
| December 31, 2023 | 43.58M |
| September 30, 2023 | 35.10M |
| June 30, 2023 | 33.10M |
| March 31, 2023 | 24.40M |
| December 31, 2022 | 23.78M |
| September 30, 2022 | 20.35M |
| June 30, 2022 | 16.69M |
| Date | Value |
|---|---|
| March 31, 2022 | 14.20M |
| December 31, 2021 | 10.14M |
| September 30, 2021 | 8.668M |
| June 30, 2021 | 8.476M |
| March 31, 2021 | 7.192M |
| December 31, 2020 | 3.221M |
| September 30, 2020 | 2.107M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.107M
Minimum
Sep 2020
44.54M
Maximum
Mar 2024
19.70M
Average
16.69M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Globus Medical Inc | 616.53M |
| Glaukos Corp | 85.62M |
| Integra Lifesciences Holdings Corp | 397.04M |
| Intuitive Surgical Inc | 1.891B |
| Masimo Corp | 548.90M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.96M |
| Total Expenses (Quarterly) | 72.19M |
| EPS Diluted (Quarterly) | -0.51 |
| Enterprise Value | 3.001B |
| Gross Profit Margin (Quarterly) | 56.21% |
| Profit Margin (Quarterly) | -58.28% |
| Earnings Yield | -3.30% |
| Normalized Earnings Yield | -3.298 |